Petefészekrák: vizsgálatok itt: Spanyolország
90 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 17.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleBI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- BioInvent International AB
See details and how to joinNCT04752826 · EU 2023-509847-29-00 - 2. fázisTaking peopleA Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Where
- Barcelona, Córdoba, Girona, L'Hospitalet de Llobregat, Madrid, Murcia, Pamplona, Valencia
- Életkor
- 18 év to 99 év
- People
- 160 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07023627 · EU 2025-521513-14-00 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- A Coruña, Barcelona, Girona, Las Palmas de Gran Canaria, Madrid, Málaga, Sabadell, Santiago de Compostela, Valencia
- Életkor
- 18 év and over
- People
- 2285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - 2/3. fázisTaking peopleRecurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
- Where
- Madrid, Murcia, Valencia
- Életkor
- 18 év and over
- People
- 138 worldwide
- Run by
- ARCAGY/ GINECO GROUP
See details and how to joinNCT03651206 - 1. fázisTaking peopleStudy to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
- Where
- Barcelona, Córdoba, Girona, L'Hospitalet de Llobregat, Logrono, Madrid, Málaga, Pamplona, Pozuelo de Alarcón, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Duke Street Bio Ltd
See details and how to joinNCT06458712 · EU 2023-508805-26-00 - 1. fázisTaking peopleA Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 187 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07306559 · EU 2025-522913-45-00 - 1/2. fázisTaking peopleA Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Where
- Barcelona, Girona, Madrid, Majadahonda, Palma, Pamplona, Pozuelo de Alarcón, Sabadell, Salamanca, Santiago de Compostela, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04104776 · EU 2023-508002-20-00 - 1/2. fázisTaking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Badalona, Barcelona, Madrid, Málaga, Pamplona
- Életkor
- 18 év and over
- People
- 1109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Barcelona, Madrid, Santiago de Compostela, Sevilla, Valencia
- Életkor
- 8 év and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - 1. fázisTaking peopleStudy of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- MOMA Therapeutics
See details and how to joinNCT06545942 - 3. fázisTaking peopleAZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Where
- A Coruña, Badalona, Barcelona, Córdoba, Donostia, Girona, L'Hospitalet de Llobregat, Madrid, Valencia
- Életkor
- 18 év and over
- People
- 1100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07218809 · EU 2025-520466-22-00 - 2. fázisTaking peopleTrial to Better Characterize the Status of HRD leading to a Benefit from Olaparib in Combination with Bevacizumab in Patients with Advanced Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer. STROBE
- Where
- Badalona, Barcelona, Córdoba, Girona, Las Palmas de Gran Canaria, L'Hospitalet de Llobregat, Madrid, Majadahonda, Palma, Sevilla, Valencia, Zaragoza
- Életkor
- 18 év and over
- People
- 100
- Run by
- Vall D Hebron Institute Of Oncology
See details and how to joinNCT06377267 · EU 2024-517363-24-00 - 1. fázisNot yet taking people in SpanyolországA Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
- Where
- Barcelona, Madrid, Pamplona
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06476808 · EU 2025-523067-38-01 - 1/2. fázisTaking peopleFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Where
- Barcelona, Logroño, Madrid, Pozuelo de Alarcón, Reus, Sevilla
- Életkor
- 18 év and over
- People
- 880 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00 - 1. fázisTaking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Barcelona, Elche, Jerez de la Frontera, Madrid, Málaga, Santander
- Életkor
- 18 év and over
- People
- 1006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - 1. fázisTaking peopleA First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
- Where
- Barcelona, Logrono, Madrid, Majadahonda, Málaga, Pamplona, Pozuelo de Alarcón, Valencia
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Stemline Therapeutics, Inc.
See details and how to joinNCT07226427 · EU 2025-524168-39-00 - No phaseTaking peoplePROV-MESH: Prophylactic Ovarian Cancer MESH
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 152
- Run by
- Hospital Vall d'Hebron
See details and how to joinNCT07676370 - 2. fázisTaking peopleA Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
- Where
- Madrid
- Életkor
- 18 év and over
- People
- 37 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT04641247 · EU 2023-506618-29-00 - 1. fázisNot yet taking people in SpanyolországStudy of STP938 (Dencatistat) in Advanced Solid Tumours
- Where
- Barcelona, Madrid, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- Step Pharma, SAS
See details and how to joinNCT06297525 · EU 2024-512375-12-00 - 1/2. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- Where
- Badalona, Barcelona, Valencia
- Életkor
- 18 év and over
- People
- 182 worldwide
- Run by
- Eisai Inc.
See details and how to joinNCT04300556 · EU 2023-506868-14-00 - No phaseTaking peoplePerformance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
- Where
- Manresa
- Életkor
- 18 év and over
- People
- 132 worldwide
- Run by
- Aesculap AG
See details and how to joinNCT06024109 - 2. fázisTaking peopleA Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
- Where
- Badalona, Barcelona, El Palmar, Jaén, Madrid, Pamplona, Seville, Valencia, Zaragoza
- Életkor
- 18 év and over
- People
- 110 worldwide
- Run by
- AbbVie
See details and how to joinNCT06682988 · EU 2024-517184-23-00 - 2. fázisTaking peopleA Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
- Where
- Barcelona, Madrid, Pamplona, Valencia
- Életkor
- 18 év and over
- People
- 114 worldwide
- Run by
- Oncoinvent Solutions AS
See details and how to joinNCT06504147 - 2. fázisBefejeződöttA basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors
- Where
- Barcelona, Madrid, Santiago de Compostela, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 101 worldwide
- Run by
- Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.
See details and how to joinNCT05642780 · EU 2022-502654-14-00 - 2. fázisTaking peopleNiraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression
- Where
- A Coruña, Barakaldo, Barcelona, Girona, Jaén, Madrid, Málaga, Oviedo, Reus, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 30
- Run by
- MedSIR
See details and how to joinNCT06180356 · EU 2023-508258-24-00